Back to search

Japan· JP-1169013F3020

ロピニロール塩酸塩

A ropinirole product containing ロピニロール塩酸塩, registered in Japan by グラクソ・スミスクライン, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.

On Japan’s NHI price listATC N04BC04

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedロピニロール塩酸塩ATCN04BC04REGISTER NO.JP-1169013F3020PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Ropinirole is registered in 19 of 19 countries.

Countries holding a registration under ATC N04BC04 (ropinirole), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 11 of them publish a price we can compare per daily dose

Ropinirole · ATC N04BC04

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ropinirole costs, country by country.

Normalised to the WHO defined daily dose (6 mg), the median price runs from $0.79 in France to $3.31 in Switzerland — a ×4.2 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ropinirole · price per daily dose (6 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.31
  • IT Italy$1.10
  • ES Spain$1.10
  • FR France$0.79
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ロピニロール塩酸塩
Manufacturer
グラクソ・スミスクライン
Country
Japan (JP)
ATC code
N04BC04
ATC class
Ropinirole
Defined daily dose
6 mg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

225 interactions on record for ropinirole.

Graded by severity as the source publishes them — 89 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ropinirole · interactions on record

225 records

  • 89 moderate
  • 134 info

Most severe, free to view

  • CimetidineA02BA01moderate
  • MetoclopramideA03FA01moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c47eb0a0-3f7e-4722-9a07-aabeb8a7f0da
GET /v1/drugs/c47eb0a0-3f7e-4722-9a07-aabeb8a7f0da?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "2mg1錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "1169013F3020",
  "category": "内用薬",
  "price_yen": 88.3,
  "generic_name": "ロピニロール塩酸塩",
  "product_name_jp": null,
  "therapeutic_class": "1169",
  "transitional_expiry": null
}

See everything about ropinirole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.